You have full text access to this OnlineOpen article

Neuropharmacology of alcohol addiction

  1. V Vengeliene,
  2. A Bilbao,
  3. A Molander,
  4. R Spanagel*

Article first published online: 29 JAN 2009

DOI: 10.1038/bjp.2008.30

Issue

British Journal of Pharmacology

British Journal of Pharmacology

Special Issue: Special Issue: Neuropharmacology of Addiction

Volume 154, Issue 2, pages 299–315, May 2008

Additional Information

How to Cite

Vengeliene, V., Bilbao, A., Molander, A. and Spanagel, R. (2008), Neuropharmacology of alcohol addiction. British Journal of Pharmacology, 154: 299–315. doi: 10.1038/bjp.2008.30

Author Information

  1. Department of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany

*Department of Psychopharmacology, Zentralinstitut für Seelische Gesundheit, University of Heidelberg, J5, Mannheim 68159, Germany. E-mail: rainer.spanagel@zi-mannheim.de

  1. DOI: 10.1038/bjp.2008.131

Publication History

  1. Issue published online: 29 JAN 2009
  2. Article first published online: 29 JAN 2009
  3. (Received November 21, 2007, Revised January 18, 2008, Accepted January 21, 2008)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (273K)

References

  • Adams CL, Lawrence AJ (2007). CGP7930: a positive allosteric modulator of the GABAB receptor. CNS Drug Rev 13: 308–316.
    Direct Link:
  • Addolorato G, Abenavoli L, Leggio L, DeLorenzi G, Ferrulli A, Caputo F et al. (2005a). Baclofen: clinical data. In: Spanagel R, Mann K (eds). Drugs for Relapse Prevention of Alcoholism. Birkhäuser: Basel. pp 171–180.
  • Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L et al. (2002). Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 37: 504–508.
  • Addolorato G, Leggio L, Abenavoli L, Gasbarrini G (2005b). On behalf of the Alcoholism Treatment Study Group neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 30: 1209–1224.
  • Allgaier C (2002). Ethanol sensitivity of NMDA receptors. Neurochem Int 41: 377–382.
  • Aragon CM, Stotland LM, Amit Z (1991). Studies on ethanol–brain catalase interaction: evidence for central ethanol oxidation. Alcohol Clin Exp Res 15: 165–169.
    Direct Link:
  • Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P et al. (1997). Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132: 104–106.
  • Bachteler D, Economidou D, Danysz W, Ciccocioppo R, Spanagel R (2005). The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. Neuropsychopharmacology 30: 1104–1110.
  • Bäckström P, Bachteler D, Koch S, Hyytiä P, Spanagel R (2004). mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29: 921–928.
  • Bäckström P, Hyytia P (2004). Ionotropic glutamate receptor modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol Clin Exp Res 28: 558–565.
    Direct Link:
  • Bäckström P, Hyytiä P (2005). Suppression of alcohol self-administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG. Eur J Pharmacol 528: 110–118.
  • Basavarajappa BS, Hungund BL (1999). Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N arachidonoylphosphatidylethanolamine in SK-N-SH cells. J Neurochem 72: 522–528.
    Direct Link:
  • Basavarajappa BS, Saito M, Cooper TB, Hungund BL (2000). Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochim Biophys Acta 1535: 78–86.
  • Bell RL, Rodd ZA, Lumeng L, Murphy JM, McBride WJ (2006). The alcohol-preferring P rat and animal models of excessive alcohol drinking. Addict Biol 11: 270–288.
    Direct Link:
  • Biala G, Kotlinska J (1999). Blockade of the acquisition of ethanol-induced conditioned place preference by N-methyl-D-aspartate receptor antagonists. Alcohol Alcohol 34: 175–182.
  • Bienkowski P, Koros E, Kostowski W, Danysz W (1999). Effects of N-methyl-D-aspartate receptor antagonists on reinforced and nonreinforced responding for ethanol in rats. Alcohol 18: 131–137.
  • Bilbao A, Rodriguez de Fonseca F (2008). Endocannabinoids and alcoholism: a new window for the treatment of alcohol relapse. Addict Biol 13 (in press).
  • Blednov YA, Stoffel M, Chang SR, Harris RA (2001). GIRK2 deficient mice. Evidence for hyperactivity and reduced anxiety. Physiol Behav 74: 109–117.
  • Blednov YA, Walker D, Osterndorf-Kahanek E, Harris RA (2004). Mice lacking metabotropic glutamate receptor 4 do not show the motor stimulatory effect of ethanol. Alcohol 34: 251–259.
  • Boehm II SL, Ponomarev I, Blednov YA, Harris RA (2006). From gene to behavior and back again: new perspectives on GABAA receptor subunit selectivity of alcohol actions. Adv Pharmacol 54: 171–203.
  • Boehm II SL, Ponomarev I, Jennings AW, Whiting PJ, Rosahl TW, Garrett EM et al. (2004). Gamma-aminobutyric acid A receptor subunit mutant mice: new perspectives on alcohol actions. Biochem Pharmacol 68: 1581–1602.
  • Botta P, Mameli M, Floyd KL, Radcliffe RA, Valenzuela CF (2007). Ethanol sensitivity of GABAergic currents in cerebellar granule neurons is not increased by a single amino acid change (R100Q) in the alpha6 GABAA receptor subunit. J Pharmacol Exp Ther 323: 684–691.
  • Bowers BJ, Wehner JM (2001). Ethanol consumption and behavioral impulsivity are increased in protein kinase C gamma null mutant mice. J Neurosci 21: RC180.
  • Boyce-Rustay JM, Holmes A (2006). Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit. Psychopharmacology (Berl) 187: 455–466.
  • Carai MAM, Agabio R, Addolorato G, Gessa GL, Colombo G (2005). Baclofen: preclinical data. In: Spanagel R, Mann K (eds). Drugs for Relapse Prevention of Alcoholism. Birkhäuser: Basel. pp 163–170.
  • Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ (2007). Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knock-out. Pharmacol Biochem Behav 86: 813–821.
  • Ciccocioppo R, Economidou D, Cippitelli A, Cucculelli M, Ubaldi M, Soverchia L et al. (2006). Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict Biol 11: 339–355.
    Direct Link:
  • Ciccocioppo R, Martin-Fardon R, Weiss F (2002). Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27: 391–399.
  • Cippitelli A, Bilbao A, Gorriti MA, Navarro M, Massi M, Piomelli D et al. (2007). The anandamide transport inhibitor AM404 reduces ethanol self-administration. Eur J Neurosci 26: 476–486.
    Direct Link:
  • Cippitelli A, Bilbao A, Hansson AC, Del Arco I, Sommer W, Heilig M et al. (2005). The European TARGALC Consortium. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. Eur J Neurosci 21: 2243–2251.
    Direct Link:
  • Clarke TK, Treutlein J, Zimmermann US, Kiefer F, Skowronek MH, Rietschel M et al. (2007). HPA-axis activity in alcoholism: examples for a gene–environment interaction. Addict Biol 13; epub ahead of print.
  • Cloninger CR (1987). Neurogenetic adaptive mechanisms in alcoholism. Science 236: 410–416.
  • Cohen C, Perrault G, Sanger DJ (1998). Preferential involvement of D3 versus D2 dopamine receptors in the effects of dopamine receptor ligands on oral ethanol self-administration in rats. Psychopharmacology (Berl) 140: 478–485.
  • Colombo G, Agabio R, Carai MA, Lobina C, Pani M, Reali R et al. (2000). Ability of baclofen in reducing alcohol intake and withdrawal severity: I-Preclinical evidence. Alcohol Clin Exp Res 24: 58–66.
  • Colombo G, Serra S, Brunetti G, Atzori G, Pani M, Vacca G et al. (2002a). The GABA(B) receptor agonists baclofen and CGP 44532 prevent acquisition of alcohol drinking behaviour in alcohol-preferring rats. Alcohol Alcohol 37: 499–503.
  • Colombo G, Serra S, Brunetti G, Gomez R, Melis S, Vacca G et al. (2002b). Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol-preferring sP rats. Psychopharmacology (Berl) 159: 181–187.
  • Colombo G, Serra S, Brunetti G, Vacca G, Carai MA, Gessa GL (2003a). Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats. Drug Alcohol Depend 70: 105–108.
  • Colombo G, Serra S, Vacca G, Carai MA, Gessa GL (2005). Endocannabinoid system and alcohol addiction: pharmacological studies. Pharmacol Biochem Behav 81: 369–380.
  • Colombo G, Vacca G, Serra S, Brunetti G, Carai MA, Gessa GL (2003b). Baclofen suppresses motivation to consume alcohol in rats. Psychopharmacology (Berl) 167: 221–224.
  • Cowen MS, Djouma E, Lawrence AJ (2005). The metabotropic glutamate 5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]-pyridine reduces ethanol self-administration in multiple strains of alcohol-preferring rats and regulates olfactory glutamatergic systems. J Pharmacol Exp Ther 315: 590–600.
  • Cowen MS, Schroff KC, Gass P, Sprengel R, Spanagel R (2003). Neurobehavioral effects of alcohol in AMPA receptor subunit (GluR1) deficient mice. Neuropharmacology 45: 325–333.
  • Crabbe JC, Phillips TJ, Feller DJ, Hen R, Wenger CD, Lessov CN et al. (1996). Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet 14: 98–101.
  • Crabbe JC, Phillips TJ, Harris RA, Arends MA, Koob GF (2006). Alcohol-related genes: contributions from studies with genetically engineered mice. Addict Biol 11: 195–269.
    Direct Link:
  • Di Chiara G, Imperato A (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85: 5274–5278.
  • Dick DM, Plunkett J, Wetherill LF, Xuei X, Goate A, Hesselbrock V et al. (2006). Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample. Alcohol Clin Exp Res 30: 1101–1110.
    Direct Link:
  • Dickinson A, Wood N, Smith JW (2002). Alcohol seeking by rats: action or habit? Q J Exp Psychol B 55: 331–348.
  • Doetkotte R, Opitz K, Kiianmaa K, Winterhoff H (2005). Reduction of voluntary ethanol consumption in alcohol-preferring Alko alcohol (AA) rats by desoxypeganine and galanthamine. Eur J Pharmacol 522: 72–77.
  • Dyr W, McBride WJ, Lumeng L, Li TK, Murphy JM (1993). Effects of D1 and D2 dopamine receptor agents on ethanol consumption in the high-alcohol-drinking (HAD) line of rats. Alcohol 10: 207–212.
  • Engel SR, Lyons CR, Allan AM (1998). 5-HT3 receptor over-expression decreases ethanol self administration in transgenic mice. Psychopharmacology (Berl) 140: 243–248.
  • Ericson M, Blomqvist O, Engel JA, Söderpalm B (1998). Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol 358: 189–196.
  • Ericson M, Molander A, Löf E, Engel JA, Söderpalm B (2003). Ethanol elevates accumbal dopamine levels via indirect activation of ventral tegmental nicotinic acetylcholine receptors. Eur J Pharmacol 467: 85–93.
  • Everitt BJ, Robbins TW (2005). Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci 8: 1481–1489.
  • Ferko AP (1994). Interaction between L-glutamate and ethanol on the central depressant properties of ethanol in mice. Pharmacol Biochem Behav 47: 351–354.
  • Ferrer B, Bermudez-Silva FJ, Bilbao A, Alvarez-Jaimes L, Sanchez-Vera I, Giuffrida A et al. (2007). Regulation of brain anandamide by acute administration of ethanol. Biochem J 404: 97–104.
  • Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF (2007). Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol Psychiatry 61: 78–86.
  • Funk D, Li Z, Shaham Y, Lê AD (2003). Effect of blockade of corticotropin-releasing factor receptors in the median raphe nucleus on stress-induced c-fos mRNA in the rat brain. Neuroscience 122: 1–4.
  • Gass JT, Olive MF (2008). Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol 75: 218–265.
  • Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C et al. (2007). 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo [1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27: 2718–2726.
  • Gerdeman GL, Partridge JG, Lupica CR, Lovinger DM (2003). It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci 26: 184–192.
  • Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu G (1985). Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348: 201–203.
  • Gessa GL, Serra S, Vacca G, Carai MA, Colombo G (2005). Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats. Alcohol Alcohol 40: 46–53.
  • Gilpin NW, Stewart RB, Murphy JM, Li TK, Badia-Elder NE (2003). Neuropeptide Y reduces oral ethanol intake in alcohol-preferring (P) rats following a period of imposed ethanol abstinence. Alcohol Clin Exp Res 27: 787–794.
    Direct Link:
  • Golovko I, Golovko SI, Leontieva LV, Zefirov YuS (2002). The influence of ethanol on the functional status of GABAA receptors. Biochemistry 67: 719–729.
  • Gonzales RA, Weiss F (1998). Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. J Neurosci 18: 10663–10671.
  • González S, Valenti M, De Miguel R, Fezza F, Fernandez-Ruiz J, Di Marzo V et al. (2004). Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. Br J Pharmacol 143: 455–464.
    Direct Link:
  • Grant KA (1999). Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures. Pharmacol Biochem Behav 6: 261–267.
  • Hansson AC, Bermudez-Silva FJ, Marinen H, Hyytia P, Sanchez-Vera I, Rimondini R et al. (2007). Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32: 117–126.
  • Hansson AC, Cippitelli A, Sommer WH, Fedeli A, Bjork K, Soverchia L et al. (2006). Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci USA 103: 15236–15241.
  • Harris RA (1999). Ethanol actions on multiple ion channels: which are important? Alcohol Clin Exp Res 23: 1563–1570.
  • Harris RA, McQuilkin SJ, Paylor R, Abeliovich A, Tonegawa S, Wehner JM (1995). Mutant mice lacking the gamma isoform of protein kinase C show decreased behavioral actions of ethanol and altered function of gamma-aminobutyrate type A receptors. Proc Natl Acad Sci USA 92: 3658–3662.
  • Hayes DM, Knapp DJ, Breese GR, Thiele TE (2005). Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains. Alcohol Clin Exp Res 29: 721–729.
    Direct Link:
  • Heidbreder CA, Andreoli M, Marcon C, Hutcheson DM, Gardner EL, Ashby Jr CR (2007). Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice. Addict Biol 12: 35–50.
    Direct Link:
  • Heilig M, Koob GF (2007). A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399–406.
  • Heilig M, Thiele TE (2005). Neuropeptide Y antagonists: a perspective. In: Spanagel R, Mann K (eds). Drugs for Relapse Prevention of Alcoholism. Birkhäuser: Basel. pp 189–204.
  • Heinz A, Löber S, Georgi A, Wrase J, Hermann D, Rey ER et al. (2003). Reward craving and withdrawal relief craving: assessment of different motivational pathways to alcohol intake. Alcohol Alcohol 38: 35–39.
  • Heinz A, Reimold M, Wrase J, Hermann D, Croissant B, Mundle G et al. (2005). Correlation of stable elevations in striatal mu-opioid receptor availability in detoxified alcoholic patients with alcohol craving: a positron emission tomography study using carbon 11-labeled carfentanil. Arch Gen Psychiatry 62: 57–64.
  • Herz A (1997). Endogenous opioid systems and alcohol addiction. Psychopharmacology (Berl) 129: 99–111.
  • Heyser CJ, Schulteis G, Durbin P, Koob GF (1998). Chronic acamprosate treatment eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18: 125–133.
  • Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF et al. (1999). Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKCɛ. Nat Neurosci 2: 997–1002.
  • Hodge CW, Miles MF, Sharko AC, Stevenson RA, Hillmann JR, Lepoutre V et al. (2006). The mGluR5 antagonist MPEP selectively inhibits the onset and maintenance of ethanol self-administration in C57BL/6J mice. Psychopharmacology (Berl) 183: 429–438.
  • Hoffman PL, Rabe CS, Grant KA, Valverius P, Hudspith M, Tabakoff B (1990). Ethanol and the NMDA receptor. Alcohol 7: 229–231.
  • Hölter SM, Danysz W, Spanagel R (2000a). Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure. J Pharmacol Exp Ther 292: 545–552.
  • Hölter SM, Henniger MS, Lipkowski AW, Spanagel R (2000b). Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology (Berl) 153: 93–102.
  • Hölter SM, Landgraf R, Zieglgänsberger W, Spanagel R (1997). Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res 21: 862–868.
    Direct Link:
  • Hölter SM, Spanagel R (1999). Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145: 360–369.
  • Homanics GE, Ferguson C, Quinlan JJ, Daggett J, Snyder K, Lagenaur C et al. (1997). Gene knockout of the alpha6 subunit of the gamma-aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol 51: 588–596.
  • Hungund BL, Basavarajappa BS (2000). Distinct differences in the cannabinoid receptor binding in the brain of C57BL/6 and DBA/2 mice, selected for their differences in voluntary ethanol consumption. J Neurosci Res 60: 122–128.
    Direct Link:
  • Hwang BH, Suzuki R, Lumeng L, Li TK, McBride WJ (2004). Innate differences in neuropeptide Y (NPY) mRNA expression in discrete brain regions between alcohol-preferring (P) and -nonpreferring (NP) rats: a significantly low level of NPY mRNA in dentate gyrus of the hippocampus and absence of NPY mRNA in the medial habenular nucleus of P rats. Neuropeptides 38: 359–368.
  • Hyytiä P (2005). Opiodergic compounds: preclinical data. In: Spanagel R, Mann K (eds). Drugs for Relapse Prevention of Alcoholism. Birkhäuser: Basel. pp 117–124.
  • Jamensky NT, Gianoulakis C (1997). Content of dynorphins and κ-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice. Alcohol Clin Exp Res 21: 1455–1464.
  • Jerlhag E, Egecioglu E, Dickson SL, Andersson M, Svensson L, Engel JA (2006a). Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward. Addict Biol 11: 45–54.
    Direct Link:
  • Jerlhag E, Egecioglu E, Dickson SL, Douhan A, Svensson L, Engel JA (2007). Ghrelin administration into tegmental areas stimulates locomotor activity and increases extracellular concentration of dopamine in the nucleus accumbens. Addict Biol 12: 6–16.
    Direct Link:
  • Jerlhag E, Grotli M, Luthman K, Svensson L, Engel JA (2006b). Role of the subunit composition of central nicotinic acetylcholine receptors for the stimulatory and dopamine-enhancing effects of ethanol. Alcohol Alcohol 41: 486–493.
  • Johnson BA (2004). An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence. Expert Opin Pharmacother 5: 1943–1955.
  • Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ (2004). Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61: 905–912.
  • June Sr HL, Foster KL, Eiler II WJ, Goergen J, Cook JB, Johnson N et al. (2007). Dopamine and benzodiazepine-dependent mechanisms regulate the EtOH-enhanced locomotor stimulation in the GABAA alpha1 subunit null mutant mice. Neuropsychopharmacology 32: 137–152.
  • June HL, Torres L, Cason CR, Hwang BH, Braun MR, Murphy JM (1998). The novel benzodiazepine inverse agonist RO19-4603 antagonizes ethanol motivated behaviors: neuropharmacological studies. Brain Res 784: 256–275.
  • Katner SN, Magalong JG, Weiss F (1999). Reinstatement of alcohol-seeking behavior by drug-associated discriminative stimuli after prolonged extinction in the rat. Neuropsychopharmacology 20: 471–479.
  • Katner SN, Weiss F (1999). Ethanol-associated olfactory stimuli reinstate ethanol-seeking behavior after extinction and modify extracellular dopamine levels in the nucleus accumbens. Alcohol Clin Exp Res 23: 1751–1760.
  • Katsura M, Shibasaki M, Hayashida S, Torigoe F, Tsujimura A, Ohkuma S (2006). Increase in expression of α1 and α2/δ1 subunits of L-type high voltage-gated calcium channels after sustained ethanol exposure in cerebral cortical neurons. J Pharmacol Sci 102: 221–230.
  • Kelaï S, Aïssi F, Lesch KP, Cohen-Salmon C, Hamon M, Lanfumey L (2003). Alcohol intake after serotonin transporter inactivation in mice. Alcohol Alcohol 38: 386–389.
  • Kobayashi T, Ikeda K, Kojima H, Niki H, Yano R, Yoshioka T, Kumanishi T (1999). Ethanol opens G-protein activated inwardly rectifying K+ channels. Nat Neurosci 2: 1091–1097.
  • Koob GF (2003). Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27: 232–243.
    Direct Link:
  • Koob GF, Le Moal M (2006). Neurobiology of Addiction. Academic Press, Elsevier: Oxford, UK.
  • Kostowski W, Bieñkowski P (1999). Discriminative stimulus effects of ethanol: neuropharmacological characterization. Alcohol 17: 63–80.
  • Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M et al. (2005). Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29: 730–738.
    Direct Link:
  • Larsson A, Jerlhag E, Svensson L, Söderpalm B, Engel JA (2004). Is an alpha-conotoxin MII-sensitive mechanism involved in the neurochemical, stimulatory, and rewarding effects of ethanol? Alcohol 34: 239–250.
  • Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B (2006). The orexin system regulates alcohol-seeking in rats. Br J Pharmacol 148: 752–759.
    Direct Link:
  • Lê AD, Funk R (2005). Serotonergic compounds: preclinical data. In: Spanagel R, Mann K (eds). Drugs for Relapse Prevention of Alcoholism. Birkhäuser: Basel. pp 95–106.
  • Lê AD, Funk D, Harding S, Juzytsch W, Fletcher PJ, Shaham Y (2006b). Effects of dexfenfluramine and 5-HT3 receptor antagonists on stress-induced reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) 186: 82–92.
  • Lê AD, Funk D, Harding S, Juzytsch W, Li Z, Fletcher PJ (2008). Intra-median raphe nucleus (MRN) infusions of muscimol, a GABA-A receptor agonist, reinstate alcohol seeking in rats: role of impulsivity and reward. Psychopharmacology (Berl) 195: 605–615.
  • Lê AD, Harding S, Juzytsch W, Fletcher PJ, Shaham Y (2002). The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 22: 7844–7849.
  • Lê AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y (2000). The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150: 317–324.
  • Lê AD, Li Z, Funk D, Shram M, Li TK, Shaham Y (2006a). Increased vulnerability to nicotine self-administration and relapse in alcohol-naive offspring of rats selectively bred for high alcohol intake. J Neurosci 26: 1872–1879.
  • Lê AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y (1999). Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21: 435–444.
  • Lê AD, Wang A, Harding S, Juzytsch W, Shaham Y (2003). Nicotine increases alcohol self-administration and reinstates alcohol seeking in rats. Psychopharmacology (Berl) 168: 216–221.
  • Le Magnen J (1960). Etude de quelques facteurs associés à des modifications de la consommation spontanée d'alcool éthylique par le rat. J Physiol (Paris) 52: 873–884.
  • Lewohl JM, Wilson WR, Mayfield RD, Brozowski SJ, Morrisett RA, Harris RA (1999). G protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat Neurosci 2: 1084–1090.
  • Littleton J (2000). Can craving be modeled in animals? The relapse prevention perspective. Addiction 95 (Suppl 2): S83–S90.
  • Liu X, Weiss F (2002a). Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22: 7856–7861.
  • Liu X, Weiss F (2002b). Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent rats. J Pharmacol Exp Ther 300: 882–889.
  • Löf E, Olausson P, Debejczy A, Stomberg R, McIntosh JM, Taylor JR et al. (2007). Nicotinic acetylcholine receptors in the ventral tegmental area mediate the dopamine activating and reinforcing properties of ethanol cues. Psychopharmacology (Berl) 195: 333–343.
  • Lovinger DM (1999). 5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic. Neurochem Int 35: 125–130.
  • Lovinger DM, White G, Weight FF (1989). Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243: 1721–1724.
  • Lovinger DM, Zhou Q (1994). Alcohols potentiate ion current mediated by recombinant 5-HT3RA receptors expressed in a mammalian cell line. Neuropharmacology 33: 1567–1572.
  • Mann K, Ackermann K, Diehl A, Ebert D, Mundle G, Nakovics H et al. (2006). Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial. Psychopharmacology (Berl) 184: 115–121.
  • Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y et al. (2007). The CRF(1) receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) 195: 345–355.
  • Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993). Animal models of drug craving. Psychopharmacology 112: 163–182.
  • McBride WJ, Li TK (1998). Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents. Crit Rev Neurobiol 12: 339–369.
  • Meyer PJ, Phillips TJ (2003). Sensitivity to ketamine, alone or in combination with ethanol, is altered in mice selectively bred for sensitivity to ethanol's locomotor effects. Alcohol Clin Exp Res 27: 1701–1709.
    Direct Link:
  • Mihalek RM, Bowers BJ, Wehner JM, Kralic JE, VanDoren MJ, Morrow AL et al. (2001). GABA(A)-receptor delta subunit knock-out mice have multiple defects in behavioral responses to ethanol. Alcohol Clin Exp Res 25: 1708–1718.
  • Mihic SJ (1999). Acute effects of ethanol on GABAA and glycine receptor function. Neurochem Int 35: 115–123.
  • Mihic SJ, Ye Q, Wick MJ, Koltchine VV, Krasowski MD, Finn SE et al. (1997). Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 389: 385–389.
  • Molander A, Lidö HH, Löf E, Ericson M, Söderpalm B (2007). The glycine reuptake inhibitor Org 25935 decreases ethanol intake and preference in male wistar rats. Alcohol Alcohol 42: 11–18.
  • Molander A, Löf E, Stomberg R, Ericson M, Söderpalm B (2005). Involvement of accumbal glycine receptors in the regulation of voluntary ethanol intake in the rat. Alcohol Clin Exp Res 29: 38–45.
    Direct Link:
  • Moriguchi S, Zhao X, Marszalec W, Yeh JZ, Narahashi T (2007). Effects of ethanol on excitatory and inhibitory synaptic transmission in rat cortical neurons. Alcohol Clin Exp Res 31: 89–99.
    Direct Link:
  • Mormede P, Colas A, Jones BC (2004). High ethanol preferring rats fail to show dependence following short- or long-term ethanol exposure. Alcohol Alcohol 39: 183–189.
  • Mottagui-Tabar S, Prince JA, Wahlestedt C, Zhu G, Goldman D, Heilig M (2005). A novel single nucleotide polymorphism of the neuropeptide Y (NPY) gene associated with alcohol dependence. Alcohol Clin Exp Res 29: 702–707.
    Direct Link:
  • Narahashi T (2000). Neuroreceptors and ion channels as the basis for drug action: past, present, and future. J Pharmacol Exp Ther 294: 1–26.
  • Narahashi T, Aistrup GL, Marszalec W, Nagata K (1999). Neuronal nicotinic acetylcholine receptors: a new target site of ethanol. Neurochem Int 35: 131–141.
  • Newton PM, Orr CJ, Wallace MJ, Kim C, Shin HS, Messing RO (2004). Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. J Neurosci 24: 9862–9869.
  • Nie H, Janak PH (2003). Comparison of reinstatement of ethanol- and sucrose-seeking by conditioned stimuli and priming injections of allopregnanolone after extinction in rats. Psychopharmacology (Berl) 168: 222–228.
  • Nowak KL, McBride WJ, Lumeng L, Li TK, Murphy JM (1998). Blocking GABA(A) receptors in the anterior ventral tegmental area attenuates ethanol intake of the alcohol-preferring P rat. Psychopharmacology (Berl) 139: 108–116.
  • Nylander I, Hyytia P, Forsander O, Terenius L (1994). Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol Clin Exp Res 8: 1272–1279.
    Direct Link:
  • Overstreet DH, Rezvani AH, Cowen M, Chen F, Lawrence AJ (2006). Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment. Addict Biol 11: 356–373.
    Direct Link:
  • Petrakis IL, Limoncelli D, Gueorguieva R, Jatlow P, Boutros NN, Trevisan L et al. (2004). Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism. Am J Psychiatry 161: 1776–1782.
  • Pfeffer AO, Samson HH (1988). Haloperidol and apomorphine effects on ethanol reinforcement in free feeding rats. Pharmacol Biochem Behav 29: 343–350.
  • Phillips TJ, Wenger CD, Dorow JD (1997). Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res 21: 691–702.
  • Pohorecky LA (1981). The interaction of alcohol and stress. A review. Neurosci Biobehav Rev 5: 209–229.
  • Quertemont E, Eriksson CJ, Zimatkin SM, Pronko PS, Diana M, Pisano M et al. (2005). Is ethanol a pro-drug? Acetaldehyde contribution to brain ethanol effects. Alcohol Clin Exp Res 29: 1514–1521.
    Direct Link:
  • Rassnick S, D'Amico E, Riley E, Koob GF (1993a). GABA antagonist and benzodiazepine partial inverse agonist reduce motivated responding for ethanol. Alcohol Clin Exp Res 17: 124–130.
    Direct Link:
  • Rassnick S, Pulvirenti L, Koob GF (1992). Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology (Berl) 109: 92–98.
  • Rassnick S, Stinus L, Koob GF (1993b). The effects of 6-hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res 623: 16–24.
  • Rezvani AH, Grady DR, Janowsky DS (1991). Effect of calcium-channel blockers on alcohol consumption in alcohol-drinking monkeys. Alcohol Alcohol 26: 161–167.
  • Rimondini R, Arlinde C, Sommer W, Heilig M (2002). Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J 16: 27–35.
  • Rimondini R, Thorsell A, Heilig M (2005). Suppression of ethanol self-administration by the neuropeptide Y (NPY) Y2 receptor antagonist BIIE0246: evidence for sensitization in rats with a history of dependence. Neurosci Lett 375: 129–133.
  • Roberts AJ, Gold LH, Polis I, McDonald JS, Filliol D, Kieffer BL et al. (2001). Increased ethanol self-administration in delta-opioid receptor knock-out mice. Alcohol Clin Exp Res 25: 1249–1256.
  • Roberts AJ, McDonald JS, Heyser CJ, Kieffer BL, Matthes HW, Koob GF et al. (2000). mu-Opioid receptor knock-out mice do not self-administer alcohol. J Pharmacol Exp Ther 293: 1002–1008.
  • Rodd ZA, McKinzie DL, Bell RL, McQueen VK, Murphy JM, Schoepp DD et al. (2006). The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats. Behav Brain Res 171: 207–215.
  • Rodd-Henricks ZA, McKinzie DL, Edmundson VE, Dagon CL, Murphy JM, McBride WJ et al. (2000). Effects of 5-HT(3) receptor antagonists on daily alcohol intake under acquisition, maintenance, and relapse conditions in alcohol-preferring (P) rats. Alcohol 21: 73–85.
  • Russell RN, McBride WJ, Lumeng L, Li TK, Murphy JM (1996). Apomorphine and 7-OH DPAT reduce ethanol intake of P and HAD rats. Alcohol 13: 515–519.
  • Salimov RM, Salimova NB (1993). The alcohol deprivation effect in hybrid mice. Drug Alcohol Depend 32: 187–191.
  • Salimov RM, Salimova NB, Shvets LN, Maisky AI (2000). Haloperidol administered subchronically reduces the alcohol-deprivation effect in mice. Alcohol 20: 61–68.
  • Sanchis-Segura C, Borchardt T, Vengeliene V, Zghoul T, Bachteler D, Gass P et al. (2006). Involvement of the AMPA receptor GluR-C subunit in alcohol-seeking behavior and relapse. J Neurosci 26: 1231–1238.
  • Sanchis-Segura C, Cline B, Jurd R, Rudolph U, Spanagel R (2007). Etomidate and propofol-hyposensitive GABAA receptor beta3(N265M) mice show little changes in acute alcohol sensitivity but enhanced tolerance and withdrawal. Neurosci Lett 416: 275–278.
  • Sanchis-Segura C, Correa M, Miquel M, Aragon CM (2005). Catalase inhibition in the arcuate nucleus blocks ethanol effects on the locomotor activity of rats. Neurosci Lett 376: 66–70.
  • Sanchis-Segura C, Spanagel R (2006). Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11: 2–38.
    Direct Link:
  • Sanna A, Congeddu E, Saba L, Porcella A, Marchese G, Ruiu S et al. (2004). The cerebellar GABAA alpha6 subunit is differentially modulated by chronic ethanol exposure in normal (R100R) and mutated (Q100Q) sNP rats. Brain Res 998: 148–154.
  • Sari Y, Bell RL, Zhou FC (2006). Effects of chronic alcohol and repeated deprivations on dopamine D1 and D2 receptor levels in the extended amygdala of inbred alcohol-preferring rats. Alcohol Clin Exp Res 30: 46–56.
    Direct Link:
  • Schmitt U, Waldhofer S, Weigelt T, Hiemke C (2002). Free-choice ethanol consumption under the influence of GABAergic drugs in rats. Alcohol Clin Exp Res 26: 457–462.
    Direct Link:
  • Schroeder JP, Overstreet DH, Hodge CW (2005a). The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) 179: 262–270.
  • Schroeder JP, Overstreet DH, Hodge CW (2005b). The neuropeptide-Y Y5 receptor antagonist L-152,804 decreases alcohol self-administration in inbred alcohol-preferring (iP) rats. Alcohol 36: 179–186.
  • Schuckit MA, Smith TL, Kalmijn J (2004). The search for genes contributing to the low level of response to alcohol: patterns of findings across studies. Alcohol Clin Exp Res 28: 1449–1458.
    Direct Link:
  • Shaham Y, Shalev U, Lu L, De Wit H, Stewart J (2003). The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berl) 168: 3–20.
  • Shelton KL, Balster RL (1997). Effects of gamma-aminobutyric acid agonists and N-methyl-D-aspartate antagonists on a multiple schedule of ethanol and saccharin self-administration in rats. J Pharmacol Exp Ther 280: 1250–1260.
  • Sinclair JD (1971). The alcohol-deprivation effect in monkeys. Psychon Sci 25: 21–22.
  • Sinclair JD, Senter RJ (1967). Increased preference for ethanol in rats following alcohol deprivation. Psychon Sci 8: 11–12.
  • Söderpalm B, Ericson M, Olausson P, Blomqvist O, Engel JA (2000). Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res 113: 85–96.
  • Sommer W, Hyytia P, Kiianmaa K (2006). The alcohol-preferring AA and alcohol-avoiding ANA rats: neurobiology of the regulation of alcohol drinking. Addict Biol 11: 289–309.
    Direct Link:
  • Sommer WH, Rimondini R, Hansson AC, Hipskind PA, Gehlert DR, Barr CS et al. (2008). Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala Crhr1 expression following a history of dependence. Biol Psychiatry 63: 139–145.
  • Spanagel R, Heilig M (2005). Addiction and its brain science. Addiction 100: 1813–1822.
    Direct Link:
  • Spanagel R, Hölter S, Allingham K, Landgraf R, Zieglgänsberger W (1996). Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305: 39–44.
  • Spanagel R, Hölter SM (2000). Controversial research areas: a critical review. In: Zernig G, Saria A, Kurz A (eds). Handbook of Alcoholism: Clinical and Theoretical Approaches. CRC Press: Boca Raton, FL. pp 401–416.
  • Spanagel R, Kiefer F (2008). Drugs for relapse prevention of alcoholism––10 years of progress. Trends Pharmacol Sci (in press).
  • Spanagel R, Pendyala G, Abarca C, Zghoul T, Sanchis-Segura C, Magnone MC et al. (2005). The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat Med 11: 35–42.
  • Spanagel R, Sigmund S, Cowen M, Schroff KC, Schumann G, Fiserova M et al. (2002). The neuronal nitric oxide synthase (nNOS) gene is critically involved in neurobehavioral effects of alcohol. J Neurosci 22: 8676–8683.
  • Spanagel R, Weiss F (1999). The dopamine hypothesis of reward: past and current status. Trends Neurosci 22: 521–527.
  • Spanagel R, Zieglgänsberger W (1997). Anti-craving compounds: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54–59.
  • Stephens DN, Brown G (1999). Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466. Alcohol Clin Exp Res 23: 1914–1920.
  • Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND (2005a). Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 164: 206–213.
  • Thanos PK, Katana JM, Ashby Jr CR, Michaelides M, Gardner EL, Heidbreder CA et al. (2005b). The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats. Pharmacol Biochem Behav 81: 190–197.
  • Thiele TE, Marsh DJ, Ste Marie L, Bernstein IL, Palmiter RD (1998). Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396: 366–369.
  • Thielen RJ, Engleman EA, Rodd ZA, Murphy JM, Lumeng L, Li TK et al. (2004). Ethanol drinking and deprivation alter dopaminergic and serotonergic function in the nucleus accumbens of alcohol-preferring rats. J Pharmacol Exp Ther 309: 216–225.
  • Thorsell A, Repunte-Canonigo V, O'Dell LE, Chen SA, King AR, Lekic D et al. (2007). Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain 130: 1330–1337.
  • Tiffany ST, Conklin CA (2000). A cognitive processing model of alcohol craving and compulsive alcohol use. Addiction 95: S145–S153.
  • Treutlein J, Kissling C, Frank J, Wiemann S, Dong L, Depner M et al. (2006). Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11: 594–602.
  • Tsai G, Coyle JT (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu Rev Med 49: 173–184.
  • Tzschentke TM (2007). Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 12: 227–462.
    Direct Link:
  • Vengeliene V, Bachteler D, Danysz W, Spanagel R (2005). The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect. Neuropharmacology 48: 822–829.
  • Vengeliene V, Heidbreder CA, Spanagel R (2007). The effects of lamotrigine on alcohol seeking and relapse. Neuropharmacology 53: 951–957.
  • Vengeliene V, Leonardi-Essmann F, Perreau-Lenz S, Gebicke-Haerter P, Drescher K, Gross G et al. (2006). The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J 20: 2223–2233.
  • Verheul R, Van Den Brink W, Geerlings P (1999). A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol 34: 197–222.
  • Walker BM, Koob GF (2008). Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33: 643–652.
  • Wallner M, Hanchar HJ, Olsen RW (2003). Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 100: 15218–15223.
  • Wang L, Liu J, Harvey-White J, Zimmer A, Kunos G (2003). Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 100: 1393–1398.
  • Wang X, Wang G, Lemos JR, Treistman SN (1994). Ethanol directly modulates gating of a dihydropyridine-sensitive Ca2+ channel in neurohypophysial terminals. J Neurosci 14: 5453–5460.
  • Wegelius K, Honkanen A, Korpi ER (1994). Benzodiazepine receptor ligands modulate ethanol drinking in alcohol-preferring rats. Eur J Pharmacol 263: 141–147.
  • Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L et al. (2006). Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11: 1016–1024.
  • Zghoul T, Abarca C, Sanchis-Segura C, Albrecht U, Schumann G, Spanagel R (2007). Ethanol self-administration and reinstatement of ethanol-seeking behavior in Per1(Brdm1) mutant mice. Psychopharmacology (Berl) 190: 13–19.
  • Zhao Y, Dayas CV, Aujla H, Baptista MA, Martin-Fardon R, Weiss F (2006). Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala. J Neurosci 26: 9967–9974.
  • Zhou FC, McKinzie DL, Patel TD, Lumeng L, Li TK (1998). Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats. Alcohol Clin Exp Res 22: 266–269.
  • Zimmermann US, Blomeyer D, Laucht M, Mann KF (2007). How gene–stress–behavior interactions can promote adolescent alcohol use: the roles of predrinking allostatic load and childhood behavior disorders. Pharmacol Biochem Behav 86: 246–262.
  • Zuo L, Kranzler HR, Luo X, Covault J, Gelernter J (2007). CNR1 variation modulates risk for drug and alcohol dependence. Biol Psychiatry 62: 616–626.
View Full Article (HTML) Get PDF (273K)